Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:10:01 EDT Sat 27 Apr 2024
Enter Symbol
or Name
USA
CA



News for U:CERE from 2023-04-27 to 2024-04-26 - 15 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-18 06:30U:CERENews ReleaseCerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
2023-12-09 08:42U:CERENews ReleaseSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, NWLI, ROVR, WAVD
2023-12-06 16:30U:CERENews ReleaseAbbVie to Acquire Cerevel Therapeutics in Transformative Transaction to Strengthen Neuroscience Pipeline
2023-11-29 06:30U:CERENews ReleaseCerevel Therapeutics to Host Investor Webcast on Tavapadon in Parkinson ¢ € ™s Disease
2023-11-08 06:30U:CERENews ReleaseCerevel Therapeutics to Present at Upcoming Investor Conferences
2023-11-01 06:30U:CERENews ReleaseCerevel Therapeutics Reports Third Quarter 2023 Financial Results and Business Updates
2023-10-13 06:30U:CERENews ReleaseCerevel Therapeutics to Report Third Quarter 2023 Financial Results and Business Updates on Wednesday, November 1, 2023
2023-10-11 22:45U:CERENews ReleaseCerevel Therapeutics Announces Pricing of $450 Million Public Offering of Common Stock
2023-10-11 16:01U:CERENews ReleaseCerevel Therapeutics Announces Proposed Public Offering of Common Stock
2023-08-29 06:30U:CERENews ReleaseCerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-02 06:30U:CERENews ReleaseCerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates
2023-07-05 06:30U:CERENews ReleaseCerevel Therapeutics to Report Second Quarter 2023 Financial Results and Business Updates on Wednesday, August 2, 2023
2023-06-15 06:30U:CERENews ReleaseCerevel Therapeutics Appoints Paul Burgess as Chief Business Development and Strategic Operations Officer
2023-05-10 06:30U:CERENews ReleaseCerevel Therapeutics Appoints Susan Altschuller, Ph.D. as Chief Financial Officer
2023-05-03 06:30U:CERENews ReleaseCerevel Therapeutics Appoints Ron Renaud as President and Chief Executive Officer and Reports First Quarter 2023 Financial Results